We're reading about drug-pricing probe, Novo board shake-up | STAT
The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground for fresh tariffs| STAT
Novità per la logistica di farmaci e dispositivi: Assoram rinasce in occasione dei suoi 60 anni come Liphe. L'articolo Farmaci: le sfide per la logistica e il debutto di Liphe proviene da Fortune Italia.| Fortune Italia
And other biotech news brought to you by The Readout| STAT
Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B| STAT
The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the president and CEO of Biocom California.| STAT
What do Rollerblades and Ozempic have in common? Host Alex Hogan explains in the latest episode of STATus Report.| STAT
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.| STAT
The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey| STAT
And other biotech news brought to you by The Readout| STAT
Awais Aftab: A Skilled and Dangerous Psychiatrist Manipulator by Peter C. Gøtzsche at Brownstone Institute Some psychiatrists are highly skilled manipulators and therefore dangerous for their patients, as I shall explain below. This applies to Awais Aftab from Cleveland, Ohio. According to Robert Whitaker, Aftab has staked out a position as being open-minded to critiques of psychiatry, which is a public stance that makes him particularly valuable to his profession. He can serve as a defender...| Brownstone Institute
Smoke, Mirrors, and the Pfizer Deal by Mollie Engelhart at Brownstone Institute I am a mother. I have never been vaccinated myself. I believe deeply in informed consent. And I want to say clearly that I am hopeful about Bobby’s leadership at HHS. I want to believe that he can bring real transparency and accountability to a government that has too often cozied up to the corporations it is supposed to regulate. But when I read the headlines about Trump’s “landmark” deal with Pfizer, I d...| Brownstone Institute
Clinical Trials Did Not Show Covid Shots Were “Safe and Effective” by Lori Weintz at Brownstone Institute I was a bit familiar, not very deeply, with this mRNA class in my professional work, when these products were in development for other things—severe conditions such as cancer. I knew that these products were inherently dangerous, which isn’t unusual in pharmaceutical research and development. We frequently work on things that are risky and can be toxic, such as chemo agents. Yet, ...| Brownstone Institute
The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground for fresh tariffs| STAT
Plus more biotech news, brought to you by The Readout.| STAT
Explore how AI is revolutionizing healthcare, from personalized treatments to smarter hearing aids, shaping the future of medicine.| AI Accelerator Institute
Our interview series is here to deliver you digestible intelligence from the organizations and innovators leading the world of AI in healthcare - through expert and in-depth interviews.| AI Accelerator Institute
Revolutionizing Pharma Supply Chains: How RTLS Ensures Compliance and Traceability in 2025 In the dynamic pharmaceutical industry, where patient safety hinges on unwavering precision, supply chain management is under intense scrutiny. As of September 2025, regulatory pressures are intensifying globally, with frameworks like the U.S. FDA's Drug Supply Chain Security Act (DSCSA) now in| Ubisense
News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive. The post Why Pharma Must Rethink How It Explains the Vaccine Schedule—Not Just Defend It appeared first on maslansky+partners.| maslansky+partners
We have heard slogan “safe and effective” ad nauseum in relation to vaccines — repeated by health agencies, media, pharmaceutical companies.| Brownstone Institute
Nobel Prize narrative is not harmless compliment. It is calculated effort to sanctify one pillar, while the others collapse beneath evidence.| Brownstone Institute
With the Ministry of Health’s latest pledge to improve upon medical legislation, international businesses continue to pin high hopes on marketing authorisation regulations for medical devices and distribution rights in order to drive their plans forward.| Vietnam Investment Review - VIR
The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Examining generative AI in healthcare: innovations, consumer views, and pressing ethical considerations.| AI Accelerator Institute
Real-world insights from the front lines of clinical AI| AI Accelerator Institute
Prior to her time at Lightstone, Gaynor worked at a number of early-stage medical device start-ups, spending more than a decade in pharma.| Silicon Republic
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease.| MedCity News
The Parkinson’s disease market across 7MM is forecast to grow at a CAGR of 7.6% from $3.4 billion in 2023 to $7.0 billion in 2033, according to GlobalData.| GlobalData
Which Location Tracking Technology is Best for Pharmaceutical Manufacturing & Labs? In pharmaceutical manufacturing and laboratory environments, precision isn’t optional — it’s essential. The margin for error is incredibly slim. A single misplaced piece of equipment, the unplanned absence of a technician, or an error in timing can ruin an entire batch or compromise| Ubisense
See how the UK's £225m Isambard-AI supercomputer is set to revolutionize drug and vaccine development using cutting-edge AI technology.| AI Accelerator Institute
Discover how the NHS’s GOSH is using large language models and AI to transform pediatric healthcare, improving outcomes for rare disease treatments.| AI Accelerator Institute
CANNES – The promise of AI-powered creative versioning and real-time optimization in healthcare marketing faces a fundamental obstacle: regulatory review processes that haven�...| Beet.TV - The Root to the Media Revolution
CANNES – The fragmentation that has long plagued television advertising may finally be giving way to consolidation, creating new opportunities for precision targeting in healthc...| Beet.TV - The Root to the Media Revolution
The $100 Billion Secret: Why Leading Pharma Companies Outsource Their Commercial Data Teams| DataKitchen
After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.| Vietnam Investment Review - VIR
AstraZeneca announced May 7th it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic. A request to withdraw it from European markets had been filed since March The company also proceeded to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe. It submitted a withdrawal […] The post Astrazeneca Withdraws The Covid-19 Vaccine From All Markets Because Of Declining Demand appeared first on He...| Healthcare Weekly
Amgen announced May 2nd financial results for the first quarter 2024, and its shares soared right after the announcement, which was followed closely by a FDA approval of a lung-cancer drug. “With many of our innovative products delivering strong growth and promising new medicines advancing through our pipeline, we are excited about delivering attractive long-term […] The post Amgen Shares Value Rose After Financial Results And New Drug Related Announcement appeared first on Healthcare Wee...| Healthcare Weekly
A new Alzheimer’s treatment could cost Medicare billions of dollars by next year — well over Wall Street or even the drug’s manufacturer projections — according to a document obtained by STAT. 5.5 million people in the U.S. suffer from Alzheimer’s disease Declining general health is natural as one grows older. However, struggling with Alzheimer’s […] The post A New Alzheimer’s Treatment Could Cost Medicare Billions of Dollars by 2025 appeared first on Healthcare Weekly.| Healthcare Weekly
AI can create models that predict a compound’s potential and run this model on millions of compounds to find the most promising options.| AI Accelerator Institute
Discover how generative AI is transforming drug discovery, medical imaging, and patient outcomes to accelerate advancements with AstraZeneca| AI Accelerator Institute
An Interview with Dr. Robert Seik, PharmD When big Pharma sold American out for Covid Profits and politics by denying treatment, independent pharmacists saved the day. Are big chain pharmacies a risk to national security? What else have our medical establishments been hiding? When big business stands in the way to good health, it’s time […] The post Independant Pharmacies Saved America appeared first on Broken Truth.| Broken Truth
Marketing Masterminds discusses how to find the top pharmaceutical sales recruiters for growing teams. Where to get the best big pharma RX sellers.| www.marketingmasterminds.org
We can’t wait for others to find a solution to high drug prices. It’s clear what should happen in a functioning drug pricing market federally and in California, but it is not happening today.| MedCity News
